Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a small update to the study record on ClinicalTrials.gov without altering the study information.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision tag updated from v3.6.3 to v3.6.4, indicating a new build or update to the page's backend/content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision version was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the documentation.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or user-facing content appears to be altered.SummaryDifference0.1%

- Check71 days agoChange DetectedResults posting details were added to the record, indicating that results were posted on 2026-06-16 with associated outcome descriptions and a linked Study Protocol and Statistical Analysis Plan PDF. The reported number of patients with dose modification due to toxicity was updated to 73 (from 75).SummaryDifference2%

- Check78 days agoChange DetectedThe page now signals that recruitment is closed and provides enhanced guidance sections to help readers understand the study details and joining process.SummaryDifference0.5%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.